OnKure Total Liab from 2010 to 2025
| OKUR Stock | 5.07 0.18 3.68% |
Total Liabilities | First Reported 2010-12-31 | Previous Quarter 158.2 M | Current Value 114.4 M | Quarterly Volatility 27.9 M |
Check OnKure Therapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OnKure Therapeutics,'s main balance sheet or income statement drivers, such as Net Interest Income of 1 M, Interest Income of 1 M or Selling General Administrative of 4.8 M, as well as many indicators such as . OnKure financial statements analysis is a perfect complement when working with OnKure Therapeutics, Valuation or Volatility modules.
OnKure |
Latest OnKure Therapeutics,'s Total Liab Growth Pattern
Below is the plot of the Total Liab of OnKure Therapeutics, over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. OnKure Therapeutics,'s Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OnKure Therapeutics,'s overall financial position and show how it may be relating to other accounts over time.
| Total Liab | 10 Years Trend |
|
Total Liab |
| Timeline |
OnKure Total Liab Regression Statistics
| Arithmetic Mean | 82,850,347 | |
| Geometric Mean | 79,615,962 | |
| Coefficient Of Variation | 33.68 | |
| Mean Deviation | 20,204,189 | |
| Median | 70,417,000 | |
| Standard Deviation | 27,903,547 | |
| Sample Variance | 778.6T | |
| Range | 87.8M | |
| R-Value | 0.64 | |
| Mean Square Error | 495.4T | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | 3,734,965 | |
| Total Sum of Squares | 11679.1T |
OnKure Total Liab History
About OnKure Therapeutics, Financial Statements
OnKure Therapeutics, shareholders use historical fundamental indicators, such as Total Liab, to determine how well the company is positioned to perform in the future. Although OnKure Therapeutics, investors may analyze each financial statement separately, they are all interrelated. The changes in OnKure Therapeutics,'s assets and liabilities, for example, are also reflected in the revenues and expenses on on OnKure Therapeutics,'s income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Liabilities | 158.2 M | 114.4 M |
Pair Trading with OnKure Therapeutics,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OnKure Therapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will appreciate offsetting losses from the drop in the long position's value.Moving against OnKure Stock
| 0.51 | DWTX | Dogwood Therapeutics, Symbol Change | PairCorr |
| 0.47 | IPA | Immunoprecise Antibodies | PairCorr |
| 0.31 | EXOZ | eXoZymes, Symbol Change | PairCorr |
The ability to find closely correlated positions to OnKure Therapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OnKure Therapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OnKure Therapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OnKure Therapeutics, to buy it.
The correlation of OnKure Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OnKure Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OnKure Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OnKure Therapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.